SLC5A2 and neurodegenerative disease: Specifically, SGLT-2 inhibitors can reduce oxidative stress and inflammation in neuronal cells, improve mitochondrial function, and enhance energy metabolism, thereby slowing the progression of neurodegenerative diseases.